Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD

INTRODUCTION: Soluble urokinase-type plasminogen activator receptor (suPAR) is upregulated by inflammation and plays a role in the pathogenesis of atherosclerosis. Chronic obstructive pulmonary disease (COPD) is associated with enhanced systemic inflammation and increased risk for atherosclerosis, h...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Lung
Prif Awduron: Böcskei, Renáta M., Benczúr, Béla, Losonczy, György, Illyés, Miklós, Cziráki, Attila, Müller, Veronika, Bohács, Anikó, Bikov, András
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer US 2019
Pynciau:
COPD
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6486892/
https://ncbi.nlm.nih.gov/pubmed/30820636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00408-019-00211-w
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg